Meglumine Acridone Acetate (Cycloferon) for COVID-19

Date of publication: April 7, 2020

Objectives:

  • To search and synthesize information on the market approval of MA in different settings.
  • To search for existing COVID-19 treatment guidelines (TGs) or clinical practice guidelines (CPG) recommending its use, as well as existing evidence on its clinical efficacy, safety and cost-effectiveness.